Helius Medical Technologies Statistics
Share Statistics
Helius Medical Technologies has 3.73M shares outstanding. The number of shares has increased by 320.43% in one year.
| Shares Outstanding | 3.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 4.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.68M |
| Failed to Deliver (FTD) Shares | 2.21K |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 225.38K, so 6.05% of the outstanding shares have been sold short.
| Short Interest | 225.38K |
| Short % of Shares Out | 6.05% |
| Short % of Float | 6.13% |
| Short Ratio (days to cover) | 0.34 |
Valuation Ratios
The PE ratio is -0.55 and the forward PE ratio is -0.23.
| PE Ratio | -0.55 |
| Forward PE | -0.23 |
| PS Ratio | 7.59 |
| Forward PS | 0.1 |
| PB Ratio | 2.08 |
| P/FCF Ratio | -0.47 |
| PEG Ratio | n/a |
Enterprise Valuation
Helius Medical Technologies Inc. has an Enterprise Value (EV) of -237.56K.
| EV / Earnings | 0.03 |
| EV / Sales | -0.37 |
| EV / EBITDA | 0.02 |
| EV / EBIT | 0.02 |
| EV / FCF | 0.02 |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.
| Current Ratio | 3.96 |
| Quick Ratio | 3.54 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.77% and return on capital (ROIC) is -516.33%.
| Return on Equity (ROE) | -3.77% |
| Return on Assets (ROA) | -1.15% |
| Return on Capital (ROIC) | -516.33% |
| Revenue Per Employee | 29.27K |
| Profits Per Employee | -402.27K |
| Employee Count | 22 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.74 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -91.1% in the last 52 weeks. The beta is 1.61, so Helius Medical Technologies 's price volatility has been higher than the market average.
| Beta | 1.61 |
| 52-Week Price Change | -91.1% |
| 50-Day Moving Average | 0.57 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 52.78 |
| Average Volume (20 Days) | 2.42M |
Income Statement
In the last 12 months, Helius Medical Technologies had revenue of 644.00K and earned -8.85M in profits. Earnings per share was -14.56.
| Revenue | 644.00K |
| Gross Profit | 61.00K |
| Operating Income | -12.43M |
| Net Income | -8.85M |
| EBITDA | -12.11M |
| EBIT | -12.43M |
| Earnings Per Share (EPS) | -14.56 |
Balance Sheet
The company has 5.18M in cash and 57.00K in debt, giving a net cash position of 5.13M.
| Cash & Cash Equivalents | 5.18M |
| Total Debt | 57.00K |
| Net Cash | 5.13M |
| Retained Earnings | -159.96M |
| Total Assets | 5.58M |
| Working Capital | 3.91M |
Cash Flow
In the last 12 months, operating cash flow was -10.42M and capital expenditures -29.00K, giving a free cash flow of -10.45M.
| Operating Cash Flow | -10.42M |
| Capital Expenditures | -29.00K |
| Free Cash Flow | -10.45M |
| FCF Per Share | -17.18 |
Margins
Gross margin is 947%, with operating and profit margins of -192.98K% and -137.42K%.
| Gross Margin | 947% |
| Operating Margin | -192.98K% |
| Pretax Margin | -137.42K% |
| Profit Margin | -137.42K% |
| EBITDA Margin | -1.88K% |
| EBIT Margin | -1.93K% |
| FCF Margin | -1.62K% |
Dividends & Yields
HSDT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2110.14% |
| FCF Yield | -406.27% |
Analyst Forecast
The average price target for HSDT is $24, which is 3378.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $24 |
| Price Target Difference | 3378.3% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 1:50.
| Last Split Date | Aug 17, 2023 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -47.54 |
| Piotroski F-Score | 1 |